Cancer-Channel Icon 

Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.

Cancer Molecular Markers


Circulating Tumor Cells


Immunotherapy Therapeutics - New


Predictive Preclinical Models in Oncology

 
>

Premier Sponsors:   

Elsevier    


Jackson Laboratory - small logo  

 

 NanoString2   


 Precision for Medicine 

 

Silicon Biosystems 

Thomson Reuters-Large